{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["32(2)"],"submitter":["Hughes JE"],"funding":["Health Research Board"],"pubmed_abstract":["<h4>Purpose</h4>In 2018, following an EU-wide safety review, a revised pregnancy prevention programme (PPP) was introduced for isotretinoin (Roaccutane®). This study aimed to examine awareness, knowledge, and experience implementing the revised isotretinoin PPP in clinical practice across three healthcare professional (HCP) groups in Ireland.<h4>Methods</h4>A cross-sectional study using anonymous online surveys among general practitioners (GPs), community pharmacists, and specialist consultants was undertaken. Descriptive analyses are presented.<h4>Results</h4>Across all HCP groups there was high (≥87%) awareness that oral isotretinoin is contraindicated in women of childbearing potential (WCBP) unless the conditions of the PPP are fulfilled, but varying awareness among GPs (54.9%) and com"],"journal":["Pharmacoepidemiology and drug safety"],"pagination":["137-147"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC10092126"],"repository":["biostudies-literature"],"pubmed_title":["Evaluating awareness, knowledge and practice of healthcare professionals following implementation of a revised pregnancy prevention programme for isotretinoin in Ireland: A multi-stakeholder cross-sectional study."],"pmcid":["PMC10092126"],"pubmed_authors":["Mullooly M","Bennett KE","Hughes JE","Looney Y","Buckley N","Kirwan G"],"additional_accession":[]},"is_claimable":false,"name":"Evaluating awareness, knowledge and practice of healthcare professionals following implementation of a revised pregnancy prevention programme for isotretinoin in Ireland: A multi-stakeholder cross-sectional study.","description":"<h4>Purpose</h4>In 2018, following an EU-wide safety review, a revised pregnancy prevention programme (PPP) was introduced for isotretinoin (Roaccutane®). This study aimed to examine awareness, knowledge, and experience implementing the revised isotretinoin PPP in clinical practice across three healthcare professional (HCP) groups in Ireland.<h4>Methods</h4>A cross-sectional study using anonymous online surveys among general practitioners (GPs), community pharmacists, and specialist consultants was undertaken. Descriptive analyses are presented.<h4>Results</h4>Across all HCP groups there was high (≥87%) awareness that oral isotretinoin is contraindicated in women of childbearing potential (WCBP) unless the conditions of the PPP are fulfilled, but varying awareness among GPs (54.9%) and com","dates":{"release":"2023-01-01T00:00:00Z","publication":"2023 Feb","modification":"2025-04-05T11:28:55.461Z","creation":"2025-04-05T11:28:55.461Z"},"accession":"S-EPMC10092126","cross_references":{"pubmed":["36073295"],"doi":["10.1002/pds.5538"]}}